临床试验

CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

NCT：NCT05731700 · COMPLETED

NCT编号NCT05731700

状态COMPLETED

开始日期2021-10-20

完成时间2025-05-08

SponsorAbbott Medical Devices (INDUSTRY)

First posted2023-02-16

Last updated2026-05-15

简要摘要

The goal of this first in human study is to assess the safety and inhibition of restenosis of the CVT Everolimus-coated PTCA Catheter in the treatment of subjects presenting in-stent restenotic lesions in native coronary arteries.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。